Pumecitinib gel

普美昔替尼凝胶

Report date: 2026/02/11 11:18:27
NME

Base Information

Drug NamePumecitinib gel
Drug Alias NamePG-011
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase JAK2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase JAK2
Therapy Area/IndicationsPrurigoVitiligoRadiodermatitis +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesPrime Gene Therapeutics Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesPrime Gene Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsPrurigoVitiligoRadiodermatitis +[8] 
Inactive IndicationsRhinitis, Allergic

Other Information

ATC CodeN/A
Related LinksN/A